Literature DB >> 6582783

The use of association data to identify family members at high risk for marker-linked diseases.

W J Conte, J I Rotter.   

Abstract

The study of genetic markers linked and associated with disease has provided important evidence of a genetic contribution to numerous diseases and has helped to establish their modes of inheritance. However, this information has not been fully utilized in counseling individuals at risk for these disorders. In the case of recessive, marker-linked diseases, such as idiopathic hemochromatosis linked to HLA in family studies and associated with specific HLA alleles in population surveys, the only current clinical application has been to identify siblings who share both HLA-marker haplotypes with the affected proband. They are considered to be presymptomatically affected, and more definitive invasive investigations are considered appropriate. All other relatives, including parents, offspring, and other siblings, who share only one marker with the proband, have been counseled only that their risk is equivalent to the gene frequency of the disease allele, for example, 3%-6% for hemochromatosis. We have developed a generally applicable method to utilize population association data to derive more specific and accurate risk figures for these other relatives of patients with marker-linked and associated diseases. We have applied this method to idiopathic hemochromatosis. If the offspring of a patient with hemochromatosis lacks A3, B7, and B14, the risk to that offspring for developing hemochromatosis is less than 2%. On the other hand, if they receive HLA A3 from their unaffected parent, their risk climbs to 9%-10%; if they receive an A3-B14 haplotype, their risk increases to virtually 100%. As demonstrated by our example, the application of association data to family members already at a basal increased risk for marker-linked disease can significantly refine the disease risk estimates given to those relatives. This information can be utilized to select individuals in whom invasive diagnostic testing or preventative intervention is indicated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6582783      PMCID: PMC1684380     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  25 in total

1.  Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing.

Authors:  M Simon; M Bourel; B Genetet; R Fauchet
Journal:  N Engl J Med       Date:  1977-11-10       Impact factor: 91.245

2.  HL-A, immune-response genes, and disease.

Authors:  H O McDevitt; W F Bodmer
Journal:  Lancet       Date:  1974-06-22       Impact factor: 79.321

Review 3.  Isolation, structure and genetics of HLA-A, -B, -C and -DRw (Ia) antigens.

Authors:  C J Barnstable; E A Jones; M J Crumpton
Journal:  Br Med Bull       Date:  1978-09       Impact factor: 4.291

4.  Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation.

Authors:  Y W Kan; A M Dozy
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

5.  Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis.

Authors:  S C FINCH; C A FINCH
Journal:  Medicine (Baltimore)       Date:  1955-12       Impact factor: 1.889

6.  Hepatic cirrhosis: a clinico-pathological review of 520 cases.

Authors:  R N MacSween; A R Scott
Journal:  J Clin Pathol       Date:  1973-12       Impact factor: 3.411

7.  Idiopathic hemochromatosis: linkage with HLA.

Authors:  M Lipinski; J Hors; J P Saleun; R Saddi; P Passa; S Lafaurie; N Feingold; J Dausset
Journal:  Tissue Antigens       Date:  1978-05

8.  Genetic mapping of the 21-hydroxylase-deficiency gene within the HLA linkage group.

Authors:  L S Levine; M Zachmann; M I New; A Prader; M S Pollack; G J O'Neill; S Y Yang; S E Oberfield; B Dupont
Journal:  N Engl J Med       Date:  1978-10-26       Impact factor: 91.245

9.  Serum ferritin as a possible marker of the hemochromatosis allele.

Authors:  C Beaumont; M Simon; R Fauchet; J P Hespel; P Brissot; B Genetet; M Bourel
Journal:  N Engl J Med       Date:  1979-07-26       Impact factor: 91.245

10.  Hereditary hemochromatosis. Phenotypic expression of the disease.

Authors:  G E Cartwright; C Q Edwards; K Kravitz; M Skolnick; D B Amos; A Johnson; L Buskjaer
Journal:  N Engl J Med       Date:  1979-07-26       Impact factor: 91.245

View more
  2 in total

1.  Analysis of DNA polymorphism haplotypes linked to the cystic fibrosis locus in North American black and Caucasian families supports the existence of multiple mutations of the cystic fibrosis gene.

Authors:  G R Cutting; S E Antonarakis; K H Buetow; L M Kasch; B J Rosenstein; H H Kazazian
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

Review 2.  DNA polymorphism and the study of disease associations.

Authors:  D N Cooper; J F Clayton
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.